You may find more results for this query on our sister sites: 360Dx and Precision Oncology News.
The test is the fourth COVID-19 molecular diagnostic to be awarded funding from BARDA. Others include Hologic, Qiagen, and DiaSorin Molecular.
Bloomberg reports the US Department of Health and Human Services suffered a cyberattack Sunday night.
The panel will aid in the diagnosis of patients with respiratory symptoms in about an hour by differentiating SARS-CoV-2 from other bacterial and viral pathogens.
The Department of Health and Human Services selected the diagnostic test for development support through a streamlined process called an easy broad agency announcement.
The US House of Representatives has passed an emergency funding bill to address the COVID-19 outbreak, the New York Times reports.
The agency is also hosting a portal for submissions and inquiries as part of the newly created Medical Countermeasures Taskforce.
If granted, emergency use authorization is anticipated to help roll out standardized, consistent 2019-nCoV testing to public health labs in the US.
The firm said that in a first phase of the contract it will focus on further development of its fever test that analyzes immune system gene expression patterns.
The firm is developing the test under a contract with the US Department of Health and Human Services' Biomedical Advanced Research and Development Authority.
The director of the Biomedical Advanced Research and Development Authority has launched two new funding programs in the past three years.
Master's and doctoral students in the UK call on funding groups to extend their grants for the duration of the disruption caused by the COVID-19 outbreak, the Guardian reports.
Squid can make edits to their RNA within the cytoplasm of their axons, Science News reports.
The Chan Zuckerberg Initiative is putting $25 million toward COVID-19 treatment research, according to the Verge.
In Science this week: researchers engineer version of Cas9 that is nearly PAM-less, and more.